| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Salarius Pharmaceuticals, Inc. (DCOY) has 2 insiders with recent SEC Form 4 filings, including 6 buys and 4 sells. DCOY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 20.2K | $115.4K | - | |
| Dir | 5.0K | $28.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2020 | McVicar William K. | Director | Buy | 8,700 | $1.15 | $10,005.00 | New | |
| Feb 11, 2020 | Northrup Jonathan P | Director | Buy | 8,700 | $1.15 | $10,005.00 | +2.5% | |
| Feb 11, 2020 | Burleson Tess | Director | Buy | 4,350 | $1.15 | $5,002.50 | New | |
| Feb 11, 2020 | Hanish Arnold C | Director | Buy | 4,350 | $1.15 | $5,002.50 | +145.0% | |
| Feb 11, 2020 | Arthur David J. | Chief Executive Officer | Buy | 2,175 | $1.15 | $2,501.25 | +2.7% | |
| Nov 25, 2019 | Hanish Arnold C | Director | Buy | 3,000 | $3.59 | $10,770.00 | +100.0% | |
| Jan 9, 2019 | Boston Foundation, Inc. | 10% Owner | Sell | 337,000 | $0.37 | $123,847.50 | -17.4% | |
| Jan 8, 2019 | Boston Foundation, Inc. | 10% Owner | Sell | 263,000 | $0.40 | $104,305.80 | -12.0% | |
| Oct 16, 2018 | Longwood Fund Ii, L.P. | 10% Owner | Sell | 3,212,861 | $0.92 | $2,941,052.96 | -100% | |
| Oct 16, 2018 | Westphal Christoph H | 10% Owner | Sell | 3,212,861 | $0.92 | $2,941,052.96 | -100% |